Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis.

CONCLUSIONS: -More dialysis patients are being started on dabigatran and rivaroxaban, even when their use is contraindicated and there are no studies to support the benefits outweigh the risks of these drugs in ESRD.
PMID: 25595139 [PubMed - as supplied by publisher]

Source: Circulation - January 16, 2015 Category: Cardiology Authors: Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW Tags: Circulation Source Type: research